Haemonetics: Mizuho Maintains Outperform, PT Lowered to $80 from $90

Friday, Feb 6, 2026 9:36 am ET1min read
HAE--

Haemonetics: Mizuho Maintains Outperform, PT Lowered to $80 from $90

Haemonetics: Mizuho Maintains Outperform, PT Lowered to $80 from $90

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet